Richard B Silverman

Winnetka, IL, United States of America

Richard B Silverman

Average Co-Inventor Count = 2.9

ph-index = 12

Forward Citations = 671(Granted Patents)

Forward Citations (Not Self Cited) = 397(Sep 21, 2024)

DiyaCoin DiyaCoin 1.25 

Inventors with similar research interests:


Location History:

  • Chicago, IL (US) (1985 - 1986)
  • Morton Grove, MI (US) (1998)
  • Morton Grove, IL (US) (1996 - 2003)
  • Northbrook, IL (2012)
  • Northbrook, IL (US) (2001 - 2018)
  • Evanston, IL (US) (2020 - 2022)
  • Winnetka, IL (US) (2014 - 2024)


Years Active: 1985-2025

where 'Filed Patents' based on already Granted Patents

106 patents (USPTO):
3 patents (CIPO):

Title: The Innovative Journey of Richard B. Silverman

Introduction: Richard B. Silverman, a distinguished inventor hailing from Winnetka, IL (US), has made significant contributions to the field of innovation with his groundbreaking work.

Latest Patents: Richard B. Silverman holds several patents in the field of pharmaceuticals and organic chemistry, with his most recent patent focusing on novel drug compounds for the treatment of neurological disorders.

Career Highlights: Throughout his illustrious career, Richard B. Silverman has been a trailblazer in the development of new drugs and treatments. His work has led to the creation of life-saving medications and therapies that have positively impacted countless lives around the world.

Collaborations: Richard B. Silverman has collaborated with leading researchers, scientists, and pharmaceutical companies to further his research and bring his inventions to market. His collaborative efforts have been instrumental in advancing the field of pharmaceuticals.

Conclusion: In conclusion, Richard B. Silverman's dedication to innovation and his pioneering spirit have solidified his legacy as a visionary inventor in the field of pharmaceuticals. His contributions continue to shape the landscape of modern medicine, making the world a better place for all.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…